Gurpreet Singh (“Ray”) Walia

E: gurpreet.walia@fisherbroyles.com

C: (516) 996-1100

T: (516) 595-3070

New York Office

Practice Areas:

  • Intellectual Property
  • International
  • Litigation – Civil Pretrial and Trial Services

Bar Admissions:

  • New Jersey
  • New York
  • U.S. District Court, District of New Jersey
  • U.S. District Court, Eastern District of New York
  • U.S. District Court, Southern District of New York
  • U.S. Court of Appeals, Federal Circuit

Education:

  • St. John’s University School of Law, JD
  • Armed Forces Medical College, MD

Large Law Firm Experience:

  • Kaye Scholer LLP

Languages: 

  • Hindi, Punjabi

Dr. Gurpreet Singh (“Ray”) Walia is a partner in our New York office.  He practices commercial and intellectual property litigation in a variety of disciplines, including pharmaceutical patent litigation and Hatch-Waxman litigation.  He represents generic pharmaceutical companies in ANDA litigation.  He also practices healthcare, regulatory, and compliance law.

Prior to law school, he completed his premedical education from Delhi University and earned a medical doctorate degree from Armed Forces Medical College, the second highest ranked medical school in India.  After completing internal medicine and anesthesiology residencies at Johns Hopkins Health System and Albert Einstein College of Medicine, he practiced as an attending anesthesiologist physician in several American hospitals.

Dr. Walia earned his J.D. from St. John’s University School of Law where he served as Editor-in-Chief of the New York Real Property Law Journal, Articles & Notes Editor of the American Bankruptcy Institute Law Review, president of the Patent Law Society, and as a member of the Moot Court Honor Society.  He previously represented branded pharmaceutical companies in ANDA litigation while at Kaye Scholer LLP, after which he has been representing generic pharmaceutical companies in major ANDA litigations.  He is fluent in Hindi and Punjabi, and has conversational knowledge of several other Indian languages.

Dr. Walia was recognized as IP Star in 2015-2017 by Managing Intellectual Property magazine, and was also recognized by Super Lawyers in 2017.  He presently serves on the Intellectual Property Committee of the Federal Bar Council.

Dr. Walia is also co-author and associate editor of the American Bar Association treatises ANDA Litigation: Strategies and Tactics for Pharmaceutical Patent Litigators (2016 edition), and Pre-ANDA Litigation: Strategies and Tactics for Developing a Drug and Patent Portfolio (2017 edition).  He has also authored several ANDA related articles for InsideCounsel magazine, and is a frequent speaker for The Knowledge Group and at other conferences.